A pharmaceutically active agent, a pharmaceutically active agent carrier andmethod of use thereof aredescribed. In some embodiments, a system may include a composition. Thecomposition may include one or morebridged polycyclic compounds. At least one of the bridged polycyclic compoundsmay include at least two cyclicgroups, and at least two pharmaceutically active agents may be associated withthe bridged polycyclic compound. Insome embodiments, a bridged polycyclic compound may be pharmaceuticallyactive. In some embodiments, abridged polycyclic compound may be function as a carrier for pharmaceuticallyactive agents.
